Prognostic analysis and validation of lncRNAs in bladder cancer on the basis of neutrophil extracellular traps

Abstract

AbstractBackgroundComplex interactions in the tumor microenvironment (TME) between bladder cancer (BLCA) and immune cells are critical for cancer progression. However, studies of neutrophil extracellular trap‐associated long non‐coding RNAs (NET‐lncRNAs) in the TME of BLCA have not been reported. This study aims to screen for NET‐lncRNAs in BLCA and to preliminarily explore their effects on BLCA development.MethodsThe correlation of NET‐related gene sets, which were identified from the cancer genome atlas (TCGA) BLCA datasets, with lncRNAs was analyzed and the prognosis‐related genes were identified through random forest analysis. The least absolute shrinkage and selection operator (LASSO) model was utilized to obtain prognostic risk scores for NET‐lncRNAs (NET‐Score). We collected clinical BLCA samples, as well as SV‐HUC‐1 and BLCA cells, to validate the expression of NET‐lncRNAs. Survival and independent prognostic analysis were performed. In J82 and UM‐UC‐3 cells, after NKILA expression was inhibited, cell proliferation and apoptosis levels were detected.ResultsNET‐related gene sets mainly included CREB5, MMP9, PADI4, CRISPLD2, CD93, DYSF, MAPK3, TECPR2, MAPK1 and PIK3CA. Then, four NET‐lncRNAs, MAP 3 K4‐AS1, MIR100HG, NKILA and THY1‐AS1, were identified. NET‐Score had the highest hazard ratio for BLCA. An elevated NET‐Score was linked to a significant increase in immune cell infiltration and copy number variation, as well as a notable decrease in survival rate and drug sensitivity. NET‐lncRNA‐related genes were mainly enriched in the pathways of angiogenesis, immune response, cell cycle and T cell activation. MAP 3 K4‐AS1, MIR100HG, NKILA and THY1‐AS1 expressions were significantly increased in BLCA tissues. Compared with SV‐HUC‐1 cells, NKILA expression was elevated in J82 and UM‐UC‐3 cells. Inhibition of NKILA expression inhibited the proliferation and promoted apoptosis of J82 and UM‐UC‐3 cells.ConclusionsSeveral NET‐lncRNAs, including MAP 3 K4‐AS1, MIR100HG, NKILA and THY1‐AS1, were successfully screened in the BLCA. The NET‐Score was an independent prognostic factor for BLCA. In addition, inhibition of NKILA expression suppressed BLCA cell development. The above NET‐lncRNAs could serve as potential prognostic markers and targets in BLCA.